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SUMMARY. Inflammatory bowel disease (IBD) is a general name of two entities: Crohn’s disease and ulcerative colitis which 
represent chronic non-specific inflammation of gastrointestinal tract. Cytomegalovirus (CMV) infection is a common viral 
infection in humans. It often causes primary infection and later persists lifelong in a latent stage. In different situations of 
immunosuppression the virus can reactivate and cause disease, affecting multiple organs including the gastrointestinal tract. 
The etiology of IBD is not clear and CMV infection is often associated with IBD. The pathogenetic link between IBD and CMV 
infection is discussed in this literature review.
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Introduction. Inflammatory bowel disease (IBD) 
represents chronic non-specific inflammation of gastro­
intestinal tract. The etiology of IBD is not clear and 
Cytomegalovirus infection is often associated with IBD. 
Early studies indicated that CMV infection can lead to 
subsequent development of IBD [1]. This may be 
possible in some susceptible patients but in the most 
recent reports CMV colitis occurred primarily in patients 
with pre-existing IBD [2, 3]. The pathogenetic link 
between IBD and CMV infection was supposed and 
began to be studied in the last decades.
The aim of the study was to evaluate critically lite­
rature data on the relationship between CMV and IBD.
Methods. Internet search was conducted in 
Medline (from 1966 to 2013) and PubMed (from 1980 
to 2013) database using words “cytomegalovirus”, 
“inflammatory bowel disease” , “ulcerative colitis”, 
“Crohn’s disease”.
Results and discussion. 419 articles were found. 
The prevalence of CMV infection is high, ranging from 
30-100 %, depending on age and race. Cytome­
galovirus is a member of the Herpesviridae family 
which contains a double-stranded DNA. Most CMV 
infections are acquired either in the perinatal period 
and infancy or in adulthood through sexual contact 
[4]. It often causes primary infection in humans, and 
later persists lifelong in a latent stage. Primary 
infection in the immunocompetent hosts is usually 
asymptomatic or causes syndrome with fever, myalgia 
and pharyngitis. Gastrointestinal affectation due to 
primary infection has been described but is rare, and 
manifests with bloody diarrhea, tenesmus, abdominal 
pain, fever, anorexia, malaise and weight loss [3]. 
CMV can cause esophagitis, gastritis, ulcers, terminal 
ileitis and colitis.
In latent infection principal reservoirs of CMV are 
fibroblasts, myeloid cells and endothelial cells [5]. 
Peripheral blood monocytes constitute a major site of 
viral latency and may be triggered by secreted 
proinflammatory cytokines and chemokines. They can 
differentiate into tissue macrophages, leading to CMV 
reactivation and probably to CMV disease. Endothelial
cells are also a common target for CMV in vivo, re­
gardless of the organ involved. The vascular endo­
thelium represents the interface between circulating 
immune cells and the lamina propria of the gut and 
this can partially explain the role of CMV in cases of 
intestinal inflammation.
The association between CMV and IBD was 
described long ago. The first case report dates from 
1961, when Powell and coauthors described a patient 
with UC and “cytomegalic inclusion” disease. Since 
then, questions about the role of CMV in these patients 
remains open [7]. Does CMV reactivation exacerbate 
the disease in patients with pre-existing IBD or is 
reactivation a consequence of IBD activity and its 
treatment with CMV acting as an innocent bystander 
[3, 8]? Interpretation of existing results is limited 
because most studies are small and retrospective, with 
different diagnostic methods of CMV detection and 
even different classifications of the severity of 
concomitant IBD.
Patients with IBD are immunosuppressed due to 
chronic inflammation, medications and poor nutrition 
[2, 9]. CMV reactivation may be triggered by TNF-b, 
catecholamines and proinflammatory prostaglandins 
[10]. During active IBD, local expression of a wide 
variety of cytokines including TNF-a, IFN-r, and IL-2 is 
induced, with activation of transcription factors (NF- 
Kb) and production of chemokines and adhesion 
molecules that recruit circulating monocytes and 
dendritic cells in the area of inflammation. There, these 
cells differentiate into permissive cells supporting active 
replication of the virus. Endothelial cells can also serve 
as permissive cells as they have been shown to 
stimulate T-cells to produce IL-2 and to proliferate. 
Activated T-cells consequently produce TNF-p and IFN-y 
and perpetuate the inflammation process causing 
more injury to the gut. These indicate that CMV has 
tropism for sites of inflammation and confirm the results 
of clinical studies that have shown presence of CMV 
in the affected region of the gut in the IBD patients. 
They also indicate that CMV replication is the result of 
CMV reactivation rather than primary infection.
142 ISSN 1811-2471. Здобутки клінічної і експериментальної медицини. 2014. № 1
Огляди літератури, оригінальні дослідження, погляд на проблему
Experimental studies have identified three factors 
that influence the reactivation of CMV infection in active 
colitis:
-  increased cell proliferation in inflamed tissue 
with ulcers that attract CMV;
-  inherent impaired natural killer cell activity 
presented by patients with IBD;
-  use of immunosuppressive drug [6].
The third factor is controversial, since use of steroids 
may be either a risk factor or a surrogate marker of 
severity disease [2,9]. In vitro data suggest that steroids 
and cyclosporine could support the replication of CMV
[11]. Recent studies suggested CMV can appear only 
in inflamed tissue and is not found in healthy tissue.
Hommes and coauthors proposed the following 
sequence to explain the pathophysiology of CMV 
disease in patients with active UC:
-  initiation phase, mucosal inflammatory response 
induces expression of cytokines and chemokines 
which activates latently infected cells and the mi­
gration of monocytes and dendritic cells into the infla­
med mucosa;
-  reactivation phase, in which infected monocytes 
differentiate into tissue macrophages and dendritic 
cells;
-  consolidation phase, during which the virus cau­
ses an active replication predominantly in endothelial 
cells that likely exacerbates inflammation [10].
Theoretically, all latently infected IBD patients 
receiving immunosuppressive treatment frequently 
produce infectious virus and don’t allow antiviral 
immune responses to develop. In two recent clinical 
studies, corticosteroids did not seem to be a major factor
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